Gene Therapy Manufacturer Expands Its Footprint in Alachua County
One in 10 Americans suffers from one of 7,000 rare diseases, defined in the U.S. as any disease affecting fewer than 200,000 people. With a relatively small community to lean on for support, managing a rare disease diagnosis can be lonely. Patients often receive multiple misdiagnoses before even learning the name of their disease.
In Alachua County, Applied Genetic Technologies Corporation (AGTC), a UF startup and UF Innovate | Sid Martin Biotech alum, is determined to change the narrative. AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system diseases. Priding itself on 20 years of gene therapy experience, AGTC has found success in designing and constructing all critical gene therapy elements and bringing them together to develop successful treatments for patients.
AGTC’s long-standing relationship with the University of Florida (UF) has brought to fruition multiple Sponsored Research Agreements to cover the exploration of new treatments and to support clinical trials and research projects that will enhance its technology platform. Its project pipeline centers on the exploration of treatment options for Optogenetics, Age-Related Macular Degeneration and Non-Syndromic Hearing Loss and Deafness.
Learn more about Gene Therapy Manufacturer Expands Its Footprint in Alachua County.